The AlphaLISA® Human TGF-β1 Detection Kit is designed for detection and quantitation of human TGF-β1 (hTGF-β1) in human serum, plasma, and cell culture supernatants using a homogeneous AlphaLISA assay (no wash steps). The assay shows negligible cross-reactivity with human hTGF-β2 and hTGF-β3.
Please enter valid quantity
Please login to add favorites
NULL OR EMPTY CART
|Part Number||Unit Size||List Price||Your Price||Quantity|
|AL336HV||100 assay points||695.00 USD|
|AL336C||500 assay points||1520.00 USD|
|AL336F||5,000 assay points||10100.00 USD|
You successfully added item(s) to your cart
Transforming growth factor beta 1 or TGF-β1, part of the TGF β cytokine superfamily, is a 25 kD disulfide-linked homodimer. TGF-β1 is produced by many cell types including immune cells and controls cell growth, proliferation, differentiation, and apoptosis by modulating many other cytokines and cytokine receptors. Serum and urine concentrations of TGF β1 are a useful marker for determining the status of patients with diabetic nephropathy in type II.
AlphaLISA technology allows the detection of molecules of interest in a no-wash, highly sensitive, quantitative assay. In an AlphaLISA assay, a biotinylated anti-analyte antibody binds to the Streptavidin-coated Donor beads while another anti-analyte antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads causes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.
Disclaimer: For research use only. Not for use in diagnostic procedures.
|Assay Target Class||Cytokine|
|Experimental Type||In vitro|
|Product Brand Name||AlphaLISA|
|Shipping Condition||Blue Ice|
|Therapeutic Area||Angiogenesis, Cancer|
|Unit Size||500 assay points|
|Resource Type||File Name||File Format|
|Brochure||Alpha product listing||PDF 128 KB|
|Data Sheet||Manual: AlphaLISA Human TGF-ß1 AL336||PDF 649 KB|
|Event||Society of Laboratory Automation & Screening (SLAS)|